Thomas A. MCCOURT - 08 May 2023 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role: Chief Executive Officer, Director
Signature: /s/ Brian Tessler, Attorney-in-Fact
Issuer symbol: IRWD
Transactions as of: 08 May 2023
Net transactions value: -$224,592
Form type: 4
Filing time: 10 May 2023, 16:05:07 UTC
Previous filing: 29 Mar 2023
Next filing: 24 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IRWD	Class A Common Stock	Sale	$224,592	-21,148	-2.5%	$10.62	820,916	08 May 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2022.
F2	The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.59 to $10.68, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Content

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2022.

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.59 to $10.68, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.